Simulations Plus (NASDAQ:SLP) Releases FY 2026 Earnings Guidance

Key Points

• Simulations Plus updated its FY 2026 guidance, projecting EPS of 0.750 to 0.850 and revenue of $79.0 million to $82.0 million. Both ranges are slightly below or near Wall Street’s consensus estimates.
• The company’s most recent quarterly results beat expectations, with EPS of $0.30 versus an estimate of $0.23 and revenue of $21.89 million versus $20.90 million.
• Despite the guidance update, the stock was up 0.4% in Friday trading, while analysts currently rate it a Hold on average with a consensus target price of $19.88.

Simulations Plus (NASDAQ:SLP - Get Free Report) issued an update on its FY 2026 earnings guidance on Friday. The company provided EPS guidance of 0.750-0.850 for the period, compared to the consensus earnings per share estimate of 0.860. The company issued revenue guidance of $79.0 million-$82.0 million, compared to the consensus revenue estimate of $81.6 million.

Simulations Plus Stock Up 0.4%

SLP opened at $18.34 on Friday. The stock has a market cap of $370.47 million, a PE ratio of -5.86 and a beta of 1.30. The business has a 50 day moving average of $16.47 and a 200-day moving average of $15.47. Simulations Plus has a 52 week low of $11.09 and a 52 week high of $21.01.

Simulations Plus (NASDAQ:SLP - Get Free Report) last issued its earnings results on Thursday, July 9th. The technology company reported $0.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.23 by $0.07. Simulations Plus had a negative net margin of 77.96% and a positive return on equity of 16.21%. The firm had revenue of $21.89 million for the quarter, compared to the consensus estimate of $20.90 million. Equities analysts anticipate that Simulations Plus will post 0.8 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on SLP. Wall Street Zen downgraded shares of Simulations Plus from a "buy" rating to a "hold" rating in a report on Saturday, June 13th. TD Cowen cut their price objective on Simulations Plus from $19.00 to $16.00 and set a "hold" rating on the stock in a research report on Friday, April 10th. Craig Hallum downgraded Simulations Plus from a "buy" rating to a "hold" rating and set a $18.50 target price for the company. in a research report on Thursday, June 18th. William Blair cut shares of Simulations Plus from an "outperform" rating to a "market perform" rating in a report on Wednesday, June 17th. Finally, Weiss Ratings raised shares of Simulations Plus from a "sell (d-)" rating to a "sell (d)" rating in a research report on Friday, June 5th. One equities research analyst has rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Simulations Plus currently has a consensus rating of "Hold" and an average target price of $19.88.

Insider Transactions at Simulations Plus

In other Simulations Plus news, Director Walter S. Woltosz sold 4,177 shares of the firm's stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $18.44, for a total transaction of $77,023.88. Following the transaction, the director owned 3,202,131 shares of the company's stock, valued at approximately $59,047,295.64. This trade represents a 0.13% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 6,177 shares of company stock worth $108,754. 19.10% of the stock is owned by corporate insiders.

Institutional Trading of Simulations Plus

A number of hedge funds have recently bought and sold shares of SLP. Raymond James Financial Inc. purchased a new position in shares of Simulations Plus in the 2nd quarter valued at $25,000. Quarry LP bought a new position in Simulations Plus in the third quarter worth about $28,000. US Bancorp DE lifted its position in shares of Simulations Plus by 32.5% during the third quarter. US Bancorp DE now owns 6,167 shares of the technology company's stock valued at $93,000 after buying an additional 1,513 shares during the last quarter. PharVision Advisers LLC bought a new stake in shares of Simulations Plus in the 3rd quarter valued at about $155,000. Finally, First Trust Advisors LP purchased a new stake in Simulations Plus during the third quarter valued at approximately $167,000. Hedge funds and other institutional investors own 78.08% of the company's stock.

Simulations Plus Company Profile

Simulations Plus, Inc NASDAQ: SLP specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company's flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.